
EU indices up this morning TA focus on Sanofi
European stocks report | Deutsche Lufthansa | Sanofi | Kuehne + Nagel
Share this:
Friday, European stocks were mixed, with the Stoxx Europe 600 Index ending flat. Germany's DAX 30 edged up less than 0.1%, the U.K.'s FTSE 100 dropped 0.4%, while France's CAC 40 was little changed.
EUROPE ADVANCE/DECLINE
45% of STOXX 600 constituents traded lower or unchanged Friday.
63% of the shares trade above their 20D MA vs 60% Thursday (below the 20D moving average).
26% of the shares trade above their 200D MA vs 25% Thursday (above the 20D moving average).
The Euro Stoxx 50 Volatility index eased 0.9pt to 31.42, a new 52w high.
SECTORS vs STOXX 600
3mths relative high: none
3mths relative low: none
Europe Best 3 sectors
media, travel & leisure, real estate
Europe worst 3 sectors
banks, energy, food & beverage
INTEREST RATE
ThThe 10yr Bund yield fell 3bps to -0.5% (above its 20D MA). The 2yr-10yr yield spread rose 0bp to -19bps (above its 20D MA).
ECONOMIC DATA
GE 07:00: Q1 GDP Growth Rate QoQ final, exp.: -0.1%
GE 07:00: Q1 GDP Growth Rate YoY final, exp.: 0.4%
GE 09:00: May Ifo expectations, exp.: 69.4
GE 09:00: May Ifo Current Conditions, exp.: 79.5
GE 09:00: May Ifo Business Climate, exp.: 74.3
FR 14:00: 6-Mth BTF auction
FR 14:00: 12-Mth BTF auction
FR 14:00: 3-Mth BTF auction
MORNING TRADING
In In Asian trading hours, EUR/USD fell to 1.0894 while GBP/USD rebounded to 1.2180. USD/JPY edged up to 107.68.
Spot gold dropped to $1,728 an ounce.
#GERMANY#
Deutsche Lufthansa's, an airline company: 9 billion euros government bailout plan slowed, amid ongoing discussions to ensure swift European Union approval, reported Bloomberg citing people familiar with the matter.
#FRANCE#
Sanofi, a pharmaceutical company, and Regeneron Pharmaceuticals announced that their Dupixent (dupilumab) eosinophilic esophagitis phase 3 trial meets both co-primary endpoints. From a chartist point of view, following a sharp pullback, the bullish dynamic, triggered by the consolidation wedge shaped between August 2015 and September 2019 has resumed. Furthermore, an ascending trend line born in 2008 is also in support. Target 100.
Source: GAIN Capital, TradingView
#SWITZERLAND#
Kuehne + Nagel, a transport and logistics company, will possibly have 20% to 25% less employees after the coronavirus pandemic, according to the company's major shareholder Klaus-Michael Kuehne cited by German newspaper Die Welt.
EX-DIVIDEND
Crédit Agricole: E0.7
Friday, European stocks were mixed, with the Stoxx Europe 600 Index ending flat. Germany's DAX 30 edged up less than 0.1%, the U.K.'s FTSE 100 dropped 0.4%, while France's CAC 40 was little changed.
EUROPE ADVANCE/DECLINE
45% of STOXX 600 constituents traded lower or unchanged Friday.
63% of the shares trade above their 20D MA vs 60% Thursday (below the 20D moving average).
26% of the shares trade above their 200D MA vs 25% Thursday (above the 20D moving average).
The Euro Stoxx 50 Volatility index eased 0.9pt to 31.42, a new 52w high.
SECTORS vs STOXX 600
3mths relative high: none
3mths relative low: none
Europe Best 3 sectors
media, travel & leisure, real estate
Europe worst 3 sectors
banks, energy, food & beverage
INTEREST RATE
ThThe 10yr Bund yield fell 3bps to -0.5% (above its 20D MA). The 2yr-10yr yield spread rose 0bp to -19bps (above its 20D MA).
ECONOMIC DATA
GE 07:00: Q1 GDP Growth Rate QoQ final, exp.: -0.1%
GE 07:00: Q1 GDP Growth Rate YoY final, exp.: 0.4%
GE 09:00: May Ifo expectations, exp.: 69.4
GE 09:00: May Ifo Current Conditions, exp.: 79.5
GE 09:00: May Ifo Business Climate, exp.: 74.3
FR 14:00: 6-Mth BTF auction
FR 14:00: 12-Mth BTF auction
FR 14:00: 3-Mth BTF auction
MORNING TRADING
In In Asian trading hours, EUR/USD fell to 1.0894 while GBP/USD rebounded to 1.2180. USD/JPY edged up to 107.68.
Spot gold dropped to $1,728 an ounce.
#GERMANY#
Deutsche Lufthansa's, an airline company: 9 billion euros government bailout plan slowed, amid ongoing discussions to ensure swift European Union approval, reported Bloomberg citing people familiar with the matter.
#FRANCE#
Sanofi, a pharmaceutical company, and Regeneron Pharmaceuticals announced that their Dupixent (dupilumab) eosinophilic esophagitis phase 3 trial meets both co-primary endpoints. From a chartist point of view, following a sharp pullback, the bullish dynamic, triggered by the consolidation wedge shaped between August 2015 and September 2019 has resumed. Furthermore, an ascending trend line born in 2008 is also in support. Target 100.
Source: GAIN Capital, TradingView
#SWITZERLAND#
Kuehne + Nagel, a transport and logistics company, will possibly have 20% to 25% less employees after the coronavirus pandemic, according to the company's major shareholder Klaus-Michael Kuehne cited by German newspaper Die Welt.
EX-DIVIDEND
Crédit Agricole: E0.7
Related tags:
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

EUR/USD weekly outlook: Oil, inflation and NFP in focus
After coming under significant pressure in recent weeks, the EUR/USD came off its lows to finish the week on a positive note on Friday, albeit with only a mild rebound. That was not enough to prevent the exchange rate falling for the third consecutive week, as the US dollar and bond yields rallied across the board.

USD/JPY Weekly Outlook: Payrolls loom as US rates remain the dominant driver
Strong US growth and hawkish Fed pricing continue to support USD/JPY, while intervention risk appears to be kicking in at lower levels

EUR/USD Q4 2026 Outlook: Euro at a Crossroads as Fed, ECB Tighten 9 25 2026
EUR/USD enters Q4 at a pivotal inflection point as competing Fed-ECB policy paths and persistent inflation risks collide with major technical support.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.






